Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Deucravacitinib effectively treats psoriasis and may help with other skin conditions.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Baricitinib is an effective treatment for severe alopecia areata.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

A group has developed therapies that show promise for treating cancer and various other conditions.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Upadacitinib effectively treats pyoderma gangrenosum.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

New cancer drugs often cause skin and nail problems.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.